Screener
Core Laboratories CLB Goodwill
Goodwill at other companies
Other financials
Where this comes from
Reported directly by Core Laboratories in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The source filing: Core Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 6:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-198109
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| PROPERTY, PLANT AND EQUIPMENT, net of accumulated depreciation of $319,112 and $320,707 at 2026 and 2025, respectively | 99,985 | 99,447 |
| RIGHT OF USE ASSETS | 54,708 | 54,346 |
| INTANGIBLES, net of accumulated amortization and impairment of $19,739 and $19,531 at 2026 and 2025, respectively | 6,893 | 7,118 |
| GOODWILL | 105,796 | 105,789 |
| DEFERRED TAX ASSETS, net | 71,296 | 67,381 |
| OTHER ASSETS | 34,679 | 35,264 |
| TOTAL ASSETS | $587,728 | $584,010 |
| LIABILITIES AND EQUITY |
Item 1. Financial Statements
FAQ
- What is Core Laboratories's goodwill?
- Core Laboratories (CLB) reported goodwill of $105.8M in Q1 2026.
- How has Core Laboratories's goodwill changed year-over-year?
- Core Laboratories's goodwill increased by 6.4% year-over-year, from $99.45M to $105.8M.
- What is the long-term trend for Core Laboratories's goodwill?
- Over 3 years (2022 to 2025), Core Laboratories's goodwill has grown at a 2.1% compound annual growth rate (CAGR), from $99.45M to $105.79M.
- What does goodwill mean?
- The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.
Ask your AI about Core Laboratories's goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude